Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase()

por Wan, Eric Yuk Fai, Wang, Boyuan, Mathur, Sukriti, Chan, Cheyenne I. Ying, Yan, Vincent Ka Chun, Lai, Francisco Tsz Tsun, Chui, Celine Sze Ling, Li, Xue, Wong, Carlos King Ho, Li, Philip Hei, Lau, Chak Sing, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Publicado 2023